Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 4/20 | 0.41 |
| ▸ | HTR2B | P41595 | 3/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | AHR | P35869 | 1/20 | 0.34 |
| ▸ | CRHBP | P24387 | 1/20 | 0.33 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5866015 | 0.72 | HTR2C (0.49) | HTR2CHTR2BHTTNPSR1 | |
| SCHEMBL381889 | 0.68 | HTR2C (0.52) | HTR2CHTR2BHTTNPSR1 | |
| SCHEMBL382367 | 0.67 | HTR2C (0.44) | HTR2CHTR2BHTTNPSR1 | |
| SCHEMBL30697691 | 0.67 | HTR2C (0.44) | HTR2CHTR2BHTTNPSR1 | |
| SCHEMBL6433379 | 0.65 | HTR2C (0.49) | HTR2CHTR2BHTTNPSR1 | |
| SCHEMBL11556099 | 0.65 | HTR2C (0.49) | HTR2CHTR2BHTTNPSR1 | |
| SCHEMBL29644871 | 0.65 | HTR2C (0.49) | HTR2CHTR2BHTTNPSR1 | |
| SCHEMBL1536905 | 0.65 | HTR2C (0.49) | HTR2CHTR2BHTTNPSR1 | |
| SCHEMBL1748567 | 0.65 | HTR2C (0.49) | HTR2CHTR2BHTTNPSR1 | |
| SCHEMBL13714754 | 0.65 | HTR2C (0.49) | HTR2CHTR2BHTTNPSR1CRHBP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5286748-A | General method of shortening the duration of common colds by application of medicaments to tissues of oral cavity | EBY III GEORGE A (US) | 1994-02-15 | — | — | US | claimed |
| US-20240165021-A1 | Prophylactic and Therapeutic Agents for Upper Respiratory Tract Infections Caused by Influenza and Other Enveloped Viruses | BROWN AMY C (US) | 2024-05-23 | — | — | US | disclosed |
| US-20160000826-A1 | Gargle Method to Reduce the Duration of Common Cold Symptoms | BROWN AMY C (US) | 2016-01-07 | — | — | US | disclosed |
| US-9072753-B1 | Gargle method to reduce the duration of common cold symptoms | BROWN AMY C (US) | 2015-07-07 | — | — | US | disclosed |
| US-6641801-B1 | Common cold is caused by a virus. Antiviral compounds that kill viruses would then be most likely to serve as a remedy for the common cold. Invention seeks to offer a unique use of an antiviral agent, ethanol (with or without additional herbs | LOVE LIVES | 2003-11-04 | — | — | US | disclosed |
| US-5286748-A | General method of shortening the duration of common colds by application of medicaments to tissues of oral cavity | EBY III GEORGE A (US) | 1994-02-15 | — | — | US | disclosed |